In collaboration with the American College of Cardiology (ACC), Evidation is conducting a nationwide initiative focusing on the lived experience of individuals with heart failure beyond the clinic walls. Our goal is to understand their particular needs and sources of value in order to improve engagement and outcomes. Since its launch in 2021, we have expanded this program to include individuals with comorbidities who could benefit from monitoring their heart health, including individuals living with COPD, diabetes, and sleep apnea.
We have enrolled more than 30,000 people with self-reported heart failure and/or chronic comorbidities into this heart-aware cohort through the Evidation app. Longitudinal real-world data (RWD) collected directly from these individuals -- such as wearable device data and surveys -- provides richer insights into how people living with heart failure adapt and manage their condition outside of clinic walls. Through this longitudinal RWD, we can identify individuals who could benefit from engagement and nudge them towards evidence-supported actions.
Take a look at some of the insights into the lived experience and patient journey that we've uncovered.
COPD Insights:
These insights were derived from an initial study for people with chronic comorbidities, from which COPD was reported as the most severe and high-impact condition.
Diagnosis: Symptoms Awareness
51% of the patients with COPD were aware of their symptoms months or years prior to diagnosis.
Why it matters:
COPD is a progressive disease that can evolve to more serious states as well as lead to the development of other new diseases, which is why an early diagnosis can be important. This can be facilitated by funneling patient input to care teams frequently, particularly when patients notice symptoms, and by potentially collecting behavioral data from wearable devices, allowing for earlier intervention when the patient is unaware of symptoms.
.avif)
Comorbidities
COPD patients report additional health conditions that increase the burden of the disease.
Why it matters:
Coexistent health conditions can have an impact on patients’ symptoms and can influence treatment, so it is important to understand the additional health conditions that individuals living with COPD report. Chronic pain and mental health conditions have been linked to socioeconomic status and general chronic illnesses, including COPD.
Patients that also report having Asthma are said to have the Asthma-COPD overlap syndrome (ACOS), which can impose even more significant respiratory impairments that lead to more severe exacerbations, thus requiring greater medical support and a specific treatment plan.
It is also important to highlight the reporting of hypertension and high cholesterol among the COPD patients, since these tend to be major risk factors for heart failure disease.
.avif)
Hospitalization: Experience and Symptoms
Many patients with COPD report the occurrence of exacerbations.
Why it matters:
Patients with COPD that report new or worsening symptoms since their last hospitalization may have had their condition evolve to a more serious state or, in the case of similar symptoms, to new, undiagnosed diseases. Research evidence shows that COPD exacerbations can, with high probability (64%), lead to cardiac alterations within just a few months. This can in turn lead to the development of heart failure and related hospitalizations and mortality.
Our findings show that patients who were last hospitalized longer ago and more frequently report worsening symptoms. Given the progressive nature of COPD, these patients should be directed to their respective care teams for a new evaluation and treatment plan.
.avif)
.avif)
.avif)
.avif)
Smoking Tendencies
The majority of the patients with COPD are smokers or former smokers.
Why it matters:
Smoking is considered the main cause of COPD. The rate of progression of COPD can be reduced when patients at risk of developing the disease stop smoking, while lifelong smokers have a 50% probability of developing COPD during their lifetime. Even those who don't smoke may still be exposed to cigarette smoke or other causal factors (i.e. air pollution and respiratory infections), so it is important to limit exposure to these as well. Furthermore, smoking is also a risk factor for developing chronic heart failure, which can significantly increase the burden of disease and complexity of treatment.
.avif)
Missing Medication: Forgetfulness
People with more symptoms also tend to miss medication more often.
Why it matters:
Therapies for COPD can be effective and improve outcomes only if 1) they are well-prescribed and 2) they are used by patients, meaning that adherence to therapy involves both the patient (i.e. health beliefs, experiences, and behaviors) and the primary care provider.
Medication adherence in chronic patients has been the focus of several studies, with evidence that patients with more severe illnesses are at greatest risk for non-adherence to treatment. However, most of the research done on this topic focuses on patients who are elderly (> 65 years old).
.avif)
Important Insights
Medication Assistance
22% reported needing help with taking their heart health medications.
Why it matters:
Medication adherence is critical for chronic disease but involves complex behaviors and components including processes and clinical and patient factors. Knowing that a set of patients will require additional help is an important first step to ensuring better ongoing care and management.
.avif)
Medication Assistance: Demographics
People that require help with medication tend to be relatively young, having lower educational levels and either multiple or no insurance.
Why it matters:
Understanding which populations require more support with medications can allow for more tailored support and drive greater medication adherence.
.avif)
Medication Assistance: Symptoms
People that require medication assistance tend to report a worsening of symptoms and more frequent personal care limitations.
Why it matters:
Living with heart failure requires both the knowledge and ability to coordinate potentially multiple medications and lifestyle changes in order to improve symptoms and quality of life. We show that there is a group of patients with heart failure who require help with medications and other aspects of their day-to-day personal care. These individuals may also be more at risk for worsening of symptoms over time (or since last hospitalization). This indicates that targeted interventions and programs that provide social and real-world support may be needed for these vulnerable patients so that they can maintain adherence to their treatments.
.avif)
Missing Medication: Changes and Forgetfulness
People that require medication assistance change medication more often, but also tend not to take them more often.
Why it matters:
Identifying triggers for needing assistance - like a recent medication change, or forgetting to take doses - can allow for the development of tools and support mechanisms (i.e. reminders, tracking apps) to improve the consistency of taking medications.
.avif)
.avif)
Missing Medication: Reasons
People that miss medications more often also tend to report more reasons for missing it. This includes side effects, complexity and financial constraints.
Why it matters:
A complex set of factors can drive missing medications. Understanding the range of root causes can allow for a more comprehensive support strategy tailored to an individual’s specific situation.
.avif)
Missing Medication: Socioeconomic Status
People that tend to miss medications more often are relatively young, with lower educational degrees and large households.
Why it matters:
Various socioeconomic factors and social determinants have been found to be related to medication adherence in those living with heart failure. Of these, we find results consistent with the existing literature, namely that those with less education report more issues with remaining adherent to their medication. We also find that younger patients are slightly more likely to report issues with medication adherence. While this may be surprising, much of the literature exploring heart failure and medication adherence tends to focus on older adults and uses coarse age range buckets (i.e. < 65 vs > 65 years old). Our findings indicate that it may be useful to explore the younger end of the heart failure patient spectrum to better understand and assist this group.
.avif)
Medication: Smoking Tendencies
People that tend to miss medications more often tend to smoke and use a walking device
Why it matters:
Previous research has indicated that smoking behavior, as well as body mass index (BMI), is associated with low medication adherence trajectories in those with heart failure. Programs should assist in early identification of patients with factors associated with a risk for low medication adherence and should apply personalized and supportive adherence management strategies and interventions.
.avif)
Medication Change
While more than half of patients actively taking medication to manage their heart health report having never changed the medications nor the dosages they are on, we see a huge range in the rates at which others report that their medication and the dosages of their medications are changed.
Why it matters:
Getting on the right medication is important for long-term management of heart failure and a patient’s quality of life. We tend to see a wide variation in medication change due to different causes such as limited access to medication, knowledge etc. Unfortunately, medications are not one size fits all and there is no one correct medication or dosage for all patients. This means that regularly monitoring patients and adjusting their medications and dosages is a key part of successful long-term management of heart failure.
.avif)
Symptoms by Medication Change
We asked patients how their symptoms changed after their most recent medication change. We saw that a change usually had no effect on specific symptoms, but often helped. However, patients on government (Medicaid, TRICARE or military) insurance, the opposite trend was seen - heart failure frequently results in a reduced ability to exercise, and patients on government insurance told us that their new medications often made this worse.
Why it matters:
When medications are changed, it is important to monitor if and how symptoms change afterwards. Having a direct connection to patients can help record which symptoms patients are experiencing and facilitate feedback to their doctor, helping them get on the right medications for them.
.avif)
Medication Impact on Well-Being
We asked patients how they were feeling overall since their last medication change. We saw that patients who changed their medications more often (i.e. monthly) felt better overall.
Why it matters:
Finding the right medications for each patient is a major challenge in heart failure, so being in regular contact with your doctor and routinely updating your medications is a key part of the journey towards well-managed heart failure. A direct connection to patients can help track how patients are feeling and nudge them towards healthy choices.
.avif)
Symptoms by Socioeconomic Status
We see that socioeconomics (i.e. employment status or the type of insurance someone is on) associates strongly with the number of symptoms an individual reports.
Why it matters:
Socioeconomics have a large influence on access to care and on outcomes in heart failure. Meeting patients where they’re at to help them manage their health is a crucial part of overcoming these disparities.
.avif)
Missing a Dose of Medication
We asked patients how often they miss a dose of their medications and why. The most common reason for occasionally missing a dose was simply because they forgot, but we also saw that many patients reported having trouble paying for medications or tried to stretch their medications to limit costs. In addition, patients who avoided or stopped taking their medications reported having concerns about the medication, experiencing side effects, or believing the medications did not work on them.
Why it matters:
Non-adherence can have serious consequences. In the simplest cases, patients need help managing their medications. However, wet we also need to help patients work with their care team to transition to the best medications for them so that they feel the benefit of taking them.
.jpeg)
Access to Healthcare
Many heart failure patients experience limitations in access to healthcare. Patients told us that the number one reason for experiencing limitations has been the pandemic.
Why it matters:
The pandemic has affected us all in so many ways, but for heart failure patients and others with chronic conditions, good access to healthcare has been heavily impacted. Enabling patients to access healthcare through other channels will help alleviate this disparity.
.avif)
Trends in Activity
We compared self-reported trends in overall health with objective behavioral data collected from consumer-grade wearables. It was found that people who reported feeling better tend to have increased their activity levels over the preceding few months.
Why it matters:
When someone is on a good track, we need objective ways to reinforce that trend. Equally, if someone is off track, we need triggers to reach out to them. This objective longitudinal RWD from consumer-grade wearables enables us to do that.
.avif)
Geographic Reach
474 heart failure participants from across the United States joined the study, representing 48/50 states and a 80:20 mix of urban and rural.
Why it matters:
Inequalities in access and treatment play a large role in heart failure outcomes. It is critical to meet patients where they are, both in their journey and physically.
.avif)
Behaviorgram
Participants shared up to 5 years of retrospective wearable data, in many cases covering their entire heart failure journey: pre-diagnosis, diagnosis, hospitalizations and medication changes, as well as current symptoms and trajectories.
Why it matters:
Participants are enabling us to understand their entire journey and study the impact of heart failure on their behavior and outcomes over long periods of time. This helps us identify individual personas and trajectories and derive personalized insights which help that individual engage with their own health.
%2520(2).jpeg)
Device Usage
We observe high levels of device usage across demographic, socioeconomic and ethnic groups.
Why it matters:
Low-burden and highly popular mobile technologies enable all patients to have their voices heard.
.jpeg)
Diagnoses
76% of participants reported being aware of their symptoms prior to diagnosis, and 25% for months or years before their diagnosis. 61% participants have a connected wearable device, of which 9% participants shared dense (no more than 4 consecutive missing days, no more than 15 days missing in a month) wearable data covering their entire journey all the way to diagnosis.
Why it matters:
Diagnosis of heart failure remains a challenge, but these data will help us to identify at-risk patients.
.avif)
Hospitalizations
89% of participants had been hospitalized at least once, and 24% participants shared dense (no more than 4 consecutive missing days, no more than 15 days missing in a month) wearable data covering their most recent hospitalization.
Why it matters:
Hospitalization is the major driver of costs associated with heart failure in the United States. This data will enable us to better understand behaviors and identify patients who are likely to be readmitted.
.jpeg)
Medication Change
11-13% report not regularly taking any medications for their heart failure, and of those that are, 53% participants reported feeling no change or worsening symptoms since last medication change
Why it matters:
The majority of patients are not receiving guideline-directed therapy. This data will help us identify sub-optimally treated individuals.
.jpeg)
Have questions? Contact Us